Organogenesis Holdings Inc. Reports Fourth Quarter and Fiscal Year 2020 Financial Results; Introduces Fiscal Year 2021 Guidance

Go back to Organogenesis Holdings Inc. Reports Fourth Quarter and Fiscal Year 2020 Financial Results; Introduces Fiscal Year 2021 Guidance
(NASDAQ: ORGO) Delayed: 1.42 --0 (-0%)
Previous Close $1.42    52 Week High
Open $1.42    52 Week Low
Day High $1.42    P/E N/A 
Day Low $1.42    EPS
Volume 411